Jeuveau (prabotulinumtoxinA-xvfs)
Moderate to Severe Glabellar Lines
ApprovedCommercial
Key Facts
About Evolus
Evolus is a commercial-stage biotech company with a mission to make the beauty experience accessible by offering high-quality aesthetic products at competitive price points. Its key achievement is establishing Jeuveau as the fastest-growing neurotoxin in the U.S. for four consecutive years and successfully launching the Evolysse dermal filler line. The company's strategy is to build a multi-product aesthetics portfolio by leveraging its commercial infrastructure, regulatory expertise, and direct sales force to in-license or acquire additional products, targeting a broad provider network of dermatologists, plastic surgeons, and medical spas.
View full company profile